STELLA PHARMA CORPORATION |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 345 JPY | +0.29% |
|
+13.91% | +20.70% |
| 02-13 | Stella Pharma Corporation Provides Earnings Guidance for the Fiscal Year Ending March 2024 | CI |
| 2023 | Stella Pharma Corporation Provides Earnings Guidance for the Fiscal Year Ending March 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 69.38M | - | - | - | - | - | |
| 595B | ||||||
| 367B | ||||||
| 334B | ||||||
| 289B | ||||||
| 239B |
